Oxford Genetics Limited is a UK-based research and experimental development company specializing in biotechnology solutions, operating from its headquarters at 5 New Street Square, London EC4A 3TW. Established in 2011 as a limited liability company (Ltd), the company focuses on providing tailored services to clients across diverse sectors including pharmaceuticals, diagnostics, and genetic engineering. Currently, Oxford Genetics Limited has an active status with registration number 07617346. The company’s core business revolves around developing innovative biotechnologies through rigorous research and development activities. While the precise scope of its offerings remains confidential due to ongoing client projects, it is primarily dedicated to supporting clients in their scientific endeavors. As a small-to-medium sized organization, Oxford Genetics Limited employs a team of skilled professionals with expertise in molecular biology, genetic analysis, and assay design. The company’s international presence allows for collaboration on global research initiatives. The current cash balance reflects a significant financial position, standing at £1,134,542 as of 2023, with two directors overseeing operations. The company's SIC codes include: - 72110: Research and experimental development on biotechnology, - 6321H: Biotechnology research and development.

Oxford Genetics Limited is a UK-based research and experimental development company specializing in biotechnology solutions, operating from its headquarters at 5 New Street Square, London EC4A 3TW. Established in 2011 as a limited liability company (Ltd), the company focuses on providing tailored services to clients across diverse sectors including pharmaceuticals, diagnostics, and genetic engineering. Currently, Oxford Genetics Limited has an active status with registration number 07617346. The company’s core business revolves around developing innovative biotechnologies through rigorous research and development activities. While the precise scope of its offerings remains confidential due to ongoing client projects, it is primarily dedicated to supporting clients in their scientific endeavors. As a small-to-medium sized organization, Oxford Genetics Limited employs a team of skilled professionals with expertise in molecular biology, genetic analysis, and assay design. The company’s international presence allows for collaboration on global research initiatives. The current cash balance reflects a significant financial position, standing at £1,134,542 as of 2023, with two directors overseeing operations. The company's SIC codes include: - 72110: Research and experimental development on biotechnology, - 6321H: Biotechnology research and development.